Linde India (523457) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
1 Sep, 2025Executive summary
Unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2024 were approved and reviewed by the Board and auditors.
Financials reflect continued operations in gases, related products, and project engineering segments.
Financial highlights
Consolidated revenue from operations for Q2 FY25 was ₹6,344.15 million, down from ₹7,113.53 million in Q2 FY24; H1 FY25 revenue was ₹12,876.44 million, down from ₹14,323.58 million year-over-year.
Consolidated profit before tax for Q2 FY25 was ₹1,433.86 million, nearly flat year-over-year; H1 FY25 profit before tax was ₹2,952.32 million, up from ₹2,772.01 million year-over-year.
Net profit for Q2 FY25 was ₹1,064.24 million, compared to ₹1,087.26 million in Q2 FY24; H1 FY25 net profit was ₹2,201.13 million, up from ₹2,086.05 million year-over-year.
Earnings per share (EPS) for Q2 FY25 was ₹12.48, compared to ₹12.75 in Q2 FY24; H1 FY25 EPS was ₹25.81, up from ₹24.46 year-over-year.
Outlook and guidance
Management continues to monitor regulatory and business risks, with uncertainties around the outcome of ongoing legal and regulatory proceedings.
Latest events from Linde India
- Q3 FY26 profit after tax rose to ₹1,933.25 million amid ongoing regulatory uncertainties.523457
Q3 25/269 Feb 2026 - Quarterly profit and revenue declined year-over-year amid ongoing SEBI regulatory scrutiny.523457
Q3 24/2518 Nov 2025 - Q2 FY26 saw strong revenue and profit growth, but regulatory risks remain elevated.523457
Q2 25/266 Nov 2025 - Q1 FY25 saw sequential profit growth amid ongoing SEBI scrutiny of related party transactions.523457
Q1 24/251 Sep 2025 - FY25 net profit rose to Rs. 4,548.45 million amid regulatory scrutiny and a 120% dividend declared.523457
Q4 24/251 Sep 2025 - Quarterly profit and revenue declined amid regulatory scrutiny and SEBI-mandated business valuation.523457
Q1 25/261 Sep 2025